Address
Form of work
SalaryHere at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve the eyesight of people worldwide. Because we’re a rapidly growing company with a dynamic, fast-paced culture, employees here are empowered with more diverse and enriching challenges than might not be possible at a larger company.
Base Salary Range: $62,300 - $81,000
Company:GlaukosIndustry:Medical Technology and PharmaceuticalLevel:Full timeLocation:United StatesCompensation:Base Salary Range: $62,300 - $81,000OVERVIEWPosition SummaryThe Clinical Research Associate (CRA) is responsible for assessing the study capabilities of potential study sites, training, on-site monitoring, closure, and management of sites participating in Clinical Research studies sponsored by Glaukos. The Clinical Research Associate (CRA) is responsible for maintaining data integrity and monitoring study conduct in accordance with regulations and the study protocol at the site level.CompensationCompensation for each successful candidate will be based on several factors, which may include qualifications, experience, education, talent availability, and local market conditions. Range listed is not inclusive of additional compensation such as bonus, equity, or additional benefits.›RESPONSIBILITIESVerifyVerify informed consent process is properly followed. Verify sites are collecting all required source data per protocol, accurately completing Case Report, Forms, and resolving all data queries. Verify and reconcile site’s essential documents against the trial master file. Verify investigational product is properly stored, dispensed, returned.ManagementGuide/manage assigned sites. Manage the progress of assigned studies by tracking subject enrollment, data collection, CRF completion, source data verification, data query generation and resolution, and investigational product accountability.AnalysisEvaluate investigator compliance with the study protocol and applicable regulations. Critically review and access site activities.TrainingConduct initial and ongoing site training throughout the course of the study.InvestigateInvestigative sites to conduct site qualification, initiation, interim monitoring, and close-out visits.TeamworkCollaborate with study management on protocol discrepancies, improving efficiency, and monitoring data integrity. Assist with selection of potential investigators.SafetyMonitor subject safety and address protocol deviations, data quality issues, and drug accountability.Quality AssuranceEnsure audit and inspection readiness.REQUIREMENTSEducationBachelor's degree in biological science, health science, nursing, health related area, or equivalent clinical experience required.SkillsProficient computer skills and experience with Microsoft Office.TravelTravel approximately 70%, including overnight, domestic and international.ExperienceExperience in the medical device and pharmaceutical industry is preferred. Ophthalmology experience is strongly preferred for all levels of a CRA.KnowledgeKnowledge of Good Clinical Practices (ICH E6 R2). Knowledge of FDA’s Code of Federal Regulations applicable to conducting Clinical Research studies.EducationBachelor's degree in biological science, health science, nursing, health related area, or equivalent clinical experience required.SkillsProficient computer skills and experience with Microsoft Office.TravelTravel approximately 70%, including overnight, domestic and international.ExperienceExperience in the medical device and pharmaceutical industry is preferred. Ophthalmology experience is strongly preferred for all levels of a CRA.KnowledgeKnowledge of Good Clinical Practices (ICH E6 R2). Knowledge of FDA’s Code of Federal Regulations applicable to conducting Clinical Research studies.EducationBachelor's degree in biological science, health science, nursing, health related area, or equivalent clinical experience required.‹›ABOUT USFounded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.
